ATOS - ATOSSA THERAPEUTICS, INC.
4.92
0.200 4.065%
Share volume: 136,363
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$4.72
0.20
0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 08-12-2024 | 11-12-2024 | 03-25-2025 | 05-13-2025 | 08-12-2025 | 11-12-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 6.980 M | 7.105 M | 6.385 M | 7.151 M | 7.414 M | 9.040 M | 9.251 M | |
| Selling general and admin | 3.232 M | 3.552 M | 2.973 M | 3.747 M | 3.257 M | 3.538 M | 3.881 M | |
| Research and development | 3.748 M | 3.553 M | 3.412 M | 3.404 M | 4.157 M | 5.502 M | 5.370 M | |
| Total expenses | 6.980 M | 7.105 M | 6.385 M | 7.151 M | 7.414 M | 9.040 M | 9.251 M | |
| 1.79% | -10.13% | 12.00% | 3.68% | 21.93% | 2.33% | |||
| Operating income | -6.980 M | -7.105 M | -6.385 M | -7.151 M | -7.414 M | -9.040 M | -9.251 M | |
| Ebit | -7.016 M | -7.122 M | -8.231 M | -5.475 M | -7.438 M | -9.068 M | -9.262 M | |
| Pretax income | -5.878 M | -6.049 M | -7.230 M | -6.347 M | -6.718 M | -8.423 M | -8.692 M | |
| 2.91% | 19.52% | -12.21% | 5.85% | 25.38% | 3.19% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -5.878 M | -6.049 M | -7.230 M | -6.347 M | -6.718 M | -8.423 M | -8.692 M | |
| -2.91% | -19.52% | 12.21% | -5.85% | -25.38% | -3.19% |